1 |
Waites KB, Xiao L, Liu Y, et al. Mycoplasma pneumoniae from the respiratory tract and beyond[J]. Clin Microbiol Rev, 2017, 30(3): 747-809.
|
2 |
Zhang XB, He W, Gui YH, et al. Current Mycoplasma pneumoniae epidemic among children in Shanghai: unusual pneumonia caused by usual pathogen[J]. World J Pediatr, 2024, 20(1): 5-10.
|
3 |
Yan C, Xue GH, Zhao HQ, et al. Current status of Mycoplasma pneumoniae infection in China[J]. World J Pediatr, 2024, 20(1): 1-4.
|
4 |
Ling Y, Zhang T, Guo W, et al. Identify clinical factors related to Mycoplasma pneumoniae pneumonia with hypoxia in children[J]. BMC Infect Dis, 2020, 20(1): 534.
|
5 |
Metsälä R, Ala-Korpi S, Rannikko J, et al. Mycoplasma pneumoniae may cause dyspnoea and hospitalisations in young healthy adults[J]. Eur J Clin Microbiol Infect Dis, 2021, 40(7): 1427-1431.
|
6 |
邹雨航,李梦瑶,张园园,等. 肺炎支原体感染检测的研究进展[J]. 中华儿科杂志,2023, 61(3): 274-277.
|
7 |
陈雪梅,丁声龙,陈远洋,等. 宏基因组学新一代测序技术诊断尿放线杆菌肺炎一例[J/CD]. 中华肺部疾病杂志(电子版), 2022, 15(5): 765-767.
|
8 |
徐伟玲,于少飞. 病原靶向二代测序在下呼吸道感染病原体诊断中应用价值研究进展[J]. 检验医学与临床,2023, 20(20): 3068-3072.
|
9 |
Meyer Sauteur PM, Beeton ML, ESGMAC the ESGMAC MAPS study group. Mycoplasma pneumoniae: gone forever?[J]. Lancet Microbe, 2023, 4(10): e763.
|
10 |
Meyer Sauteur PM, Beeton ML, Uldum SA, et al. Mycoplasma pneumoniae detections before and during the COVID-19 pandemic: results of a global survey, 2017 to 2021[J]. Euro Surveill, 2022, 27(19): 2100746.
|
11 |
Meyer Sauteur PM, Beeton ML, European society of clinical Microbiology and infectious diseases (ESCMID) study group for Mycoplasma, et al. Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions[J]. Lancet Microbe, 2024, 5(2): e100-e101.
|
12 |
Lv YT, Sun XJ, Chen Y, et al. Epidemic characteristics of Mycoplasma pneumoniae infection: a retrospective analysis of a single center in Suzhou from 2014 to 2020[J]. Ann Transl Med, 2022, 10(20): 1123-1123.
|
13 |
Wang X, Li M, Luo M, et al. Mycoplasma pneumoniae triggers pneumonia epidemic in autumn and winter in Beijing: a multicentre, population-based epidemiological study between 2015 and 2020[J]. Emerg Microbes Infect, 2022, 11(1): 1508-1517.
|
14 |
Gong C, Zhang T, Luo M, et al. Distribution of the atypical pathogens of community-acquired pneumonia to disease severity[J]. J Thorac Dis, 2018, 10(11): 5991-6001.
|
15 |
Ren Y, Wang Y, Liang R, et al. Development and validation of a nomogram for predicting Mycoplasma pneumoniae pneumonia in adults[J]. Sci Rep, 2022, 12(1): 21859.
|
16 |
Shangguan Z, Sun Q, Zhang M, et al. Mycoplasma pneumoniae infection in hospitalized adult patients with community-acquired pneumonia in China[J]. J Infect Dev Ctries, 2014, 8(10): 1259-1266.
|
17 |
Nordholm AC, Søborg B, Jokelainen P, et al. Mycoplasma pneumoniae epidemic in Denmark, October to December, 2023[J]. Euro Surveill, 2024, 29(2): 2300707.
|
18 |
Izumikawa K, Izumikawa K, Takazono T, et al. Clinical features, risk factors and treatment of fulminant Mycoplasma pneumoniae pneumonia: a review of the Japanese literature[J]. J Infect Chemother, 2014, 20(3): 181-185.
|
19 |
Li M, Wei X, Zhang SS, et al. Recognition of refractory Mycoplasma pneumoniae pneumonia among Myocoplasma pneumoniae pneumonia in hospitalized children: development and validation of a predictive nomogram model[J]. BMC Pulm Med, 2023, 23(1): 383.
|
20 |
Wang Y, Yu X, Liu F, et al. Respiratory microbiota imbalance in children with Mycoplasma pneumoniae pneumonia[J]. Emerg Microbes Infect, 2023, 12(1): 2202272.
|
21 |
赵 枫,史 亚,王 莹,等. PCR反应条件对16S rRNA基因扩增子测序准确性的影响[J]. 微生物学通报,2022, 49(7): 2527-2537.
|
22 |
de Muinck EJ, Trosvik P, Gilfillan GD, et al. A novel ultra high-throughput 16S rRNA gene amplicon sequencing library preparation method for the Illumina HiSeq platform[J]. Microbiome, 2017, 5(1): 68.
|
23 |
赵顺英,钱素云,陈志敏,等. 儿童肺炎支原体肺炎诊疗指南(2023年版)[J]. 传染病信息,2023, 36(4): 291-297.
|
24 |
Lee KL, Lee CM, Yang TL, et al. Severe Mycoplasma pneumoniae pneumonia requiring intensive care in children, 2010-2019[J]. J Formos Med Assoc, 2021, 120(1 Pt 1): 281-291.
|
25 |
Miyashita N, Obase Y, Ouchi K, et al. Clinical features of severe Mycoplasma pneumoniae pneumonia in adults admitted to an intensive care unit[J]. J Med Microbiol, 2007, 56(Pt 12): 1625-1629.
|
26 |
Cao B, Qu JX, Yin YD, et al. Overview of antimicrobial options for Mycoplasma pneumoniae pneumonia: focus on macrolide resistance[J]. Clin Respir J, 2017, 11(4): 419-429.
|
27 |
宋莉红,肖红丽,辛德莉,等. 成人肺炎支原体急性感染致社区获得性肺炎的临床特征:一项多中心横断面研究[J]. 中华危重病急救医学,2016, 28(6): 492-497.
|
28 |
Chen YC, Hsu WY, Chang TH. Macrolide-resistant Mycoplasma pneumoniae Infections in pediatric community-acquired pneumonia[J]. Emerg Infect Dis, 2020, 26(7): 1382-1391.
|
29 |
Lin L, Zhang R, Zhang Z, et al. Clinical value of metagenomics next-generation sequencing in antibiotic resistance of a patient with severe refractory Mycoplasma pneumoniae pneumonia: A case report[J]. Infect Drug Resist, 2023, 16: 4593-4597.
|
30 |
陈志敏,求伟玲. 儿童肺炎支原体肺炎治疗进展[J] . 中华实用儿科临床杂志,2021, 36(16): 1214-1217.
|
31 |
Tsai TA, Tsai CK, Kuo KC, et al. Rational stepwise approach for Mycoplasma pneumoniae pneumonia in children[J]. J Microbiol Immunol Infect, 2021, 54(4): 557-565.
|
32 |
Kim K, Jung S, Kim M, et al. Global trends in the proportion of macrolide-resistant mycoplasma pneumoniae infections[J]. JAMA Netw Open, 2022, 5(7): e2220949.
|